Scientists dosed the first patient this week in a small clinical trial of an experimental cancer treatment—one that relies on a novel kind of ally. The treatment uses a virus engineered to selectively kill cancer cells, while also amplifying the body’s immune response to the cancer. The hope is that this therapy can help those with advanced solid tumor cancers, in combination with other existing drugs.
The CF33-hNIS virus, also called Vaxinia, was originally created by researchers at the City of Hope National Medical Center in California. It’s now being jointly developed with the company Imugene Limited.
Vaxinia is billed as an oncolytic virus, meaning it prefers to target and infect tumor cells. Scientists have been hopeful about using these kinds of viruses to directly kill off cancer cells for more than a century, but with limited success so far. In recent years, some teams have decided to explore a slightly different plan of attack. This genetically modified virus not only infects and harms cancer cells, but also forces these cells to become more recognizable to the immune system.
This strategy, the researchers hope, will then allow other treatments that also boost our immune response to cancer cells to be more effective, particularly against hard-to-target solid tumors. These treatments are collectively known as immunotherapy. In early animal and lab experiments, the virus has been shown to reduce the size of colon, lung, breast, ovarian, and pancreatic cancer tumors.
After World War II, the possibility of gaining control over a person’s mind became one of the top pursuits for intelligence services. Amid never-ending spy games, the capacity to make someone tell the full truth during an interrogation, or to wipe out a subject’s personality and impose another – perhaps, a controlled one – became quite attractive to secret services.
In 1979, former US State Department officer John Marks published a book called “The Search for the ‘Manchurian Candidate’,” which focused on the CIA’s mind-control experiments and is based on agency documents released under the Freedom of Information Act.
The term ‘Manchurian Candidate’ emerged from a title of a novel by Richard Condon, first published in 1959, which tells the story of a US soldier brainwashed and turned into an assassin by the Communists. Back then, the fear that America’s rivals might use such techniques was not only a fictional fantasy, but a matter of very serious concern.
This is how John Marks describes it: “In 1947 the National Security Act created not only the CIA but also the National Security Council – in sum, the command structure for the Cold War. Wartime [Office of Strategic Services] leaders like William Donovan and Allen Dulles lobbied feverishly for the Act. Officials within the new command structure soon put their fears and their grandiose notions to work. Reacting to the perceived threat, they adopted a ruthless and warlike posture toward anyone they considered an enemy – most especially the Soviet Union. They took it upon themselves to fight communism and things that might lead to communism everywhere in the world.”
The risky procedure will involve taking the reproductive organs from a dead donor or a patient who has transitioned the other way and had theirs removed.
There has only been one documented case of a womb being inserted into a trans woman in the past — but she died from complications just months later.
Impregnating a trans woman would be an even bigger feat, and would require the use of IVF and a C-section, because they do not have a fully functioning vagina.
Dr Narendra Kaushik, who runs a gender reassignment clinic in New Delhi, has said he is ‘very, very optimistic’ he can make a success of the procedure.
‘Every transgender woman wants to be as female as possible — and that includes being a mother,’ he is quoted as saying in The Mirror.
In order to “protect its allies against Russia,” the United States performed biological weapons “experiments” on Ukrainian and Georgian soldiers, newly leaked documents show.
Even though both Ukraine and Georgia are considered to be American allies, the Pentagon decided to harm these countries’ soldiers as part of a $2.5 billion Defense Threat Reduction Agency (DTRA) biological engagement program, which included research on biological agents, deadly viruses and antibiotic-resistant bacteria.
Each type of pathogen was unleashed on local populations in both countries as well, exposing potentially millions of people to deadly infections. (Related: The Pentagon’s secret operations programs in Ukraine date at least as far back as 2005.)
A five-year Pentagon operation in Georgia, code-named GG-21, involved “Arthropod-borne and zoonotic infections among military personnel in Georgia.” The project’s description explains that blood samples were collected from 1,000 military recruits at the time of their registration and physical exam at the Georgian military hospital located in Gori.
Synchron Inc., which develops a so-called brain-computer interface and competes with Elon Musk’s Neuralink Corp., enrolled the first patient in its U.S. clinical trial, putting the company’s implant on a path toward possible regulatory approval for wider use in people with paralysis.
The early feasibility study is funded by the National Institutes of Health and will evaluate the safety of the device, known as the Stentrode, the New York-based company said. It will also assess how effective the Stentrode is in helping patients control digital devices hands-free.
The trial represents a landmark for Synchron, the first startup working on brain-machine interfaces to begin a clinical trial seeking approval to sell its product. It also puts Synchron ahead of Neuralink, which is better funded but is still recruiting a trial director. Neuralink raised $205 million last year. Synchron has raised $70 million total.
Most Americans do not realize that their tax dollars are being used to fund programs that can lead to the enslavement of humanity in ways that have never before been imagined.
The U.S. government’s Defense Advanced Research Projects Agency (DARPA) has launched a research program to analyze individuals ‘ “preconscious brain signals” to determine people’s thoughts and feelings. Dr. Yuval Noah Harari, the Chief Advisor to the World Economic Forum’s leader, Klaus Schwab, and other futurists have often warned that humans would soon be hackable. Nevertheless, governments and unelected globalists’ ambitions to reshape humanity and gain control over every aspect of our lives and bodies are making successful strides.
Under the guise of identifying soldiers at risk of depression and suicide, the Pentagon’s Research Arm, DARPA, launched the Neural Evidence Aggregation Tool (NEAT) program, which focuses on “aggregating preconscious brain signals to determine what someone believes to be true.”
According to DARPA’s press release, “NEAT aims to develop a new cognitive science tool that identifies people at risk of suicide by using preconscious brain signals rather than asking questions and waiting for consciously filtered responses.”
NEAT will achieve its goals by “bringing together recent advances in cognitive science, neuroscience, physiological sensors, data science, and machine learning.” Connecting the human brain to machines has been a longtime goal of all globalists and their organizations.
The United States’ new tool will give governments, corporations, and supranational organizations, such as the World Economic Forum, the ability to hack human beings on the preconscious level.
Recently released emails show National Institutes of Health (NIH) Director Francis Collins agreeing to a Zoom meeting with University of Pittsburgh (Pitt) administrators apparently to downplay allegations about the university’s experiments on aborted babies.
Last fall, revelations about the University of Pittsburgh’s fetal tissue research sparked outrage that the institution may have received organs that were extracted from live fetuses, or that tissue may have come from abortions that violated federal anti-trafficking law. Now, emails obtained by Judicial Watch indicate Biden’s NIH may have been working behind the scenes in collusion with Pitt to dampen the news and the pushback that followed it.
In the early 1950s, the U.S. Army Chemical Corps prepared a series of biological weapons tests in multiple cities across the United States and Canada. These experiments were executed in the mid-1950s through the late 1960s—not before a law was passed to shield private military contractors from all liability for public injury.
As Professor Lisa Martino-Taylor writes, this, in effect: “created a sanction-free military human test zone across North America and blocked legal recourse for victims.”
In short, the Army was ostensibly concerned that the Russians would expose American and Canadian civilians to dangerous agents, so the Army did it themselves in the name of mitigation.
As a part of the tests, the U.S. Army Chemical Corps released zinc cadmium sulfide “from airplanes, rooftops, and moving vehicles in 33 locations, mostly cities and towns, in the United States and Canada.” These cities included St. Louis, MO, Minneapolis, MN, Corpus Christi, TX, Fort Wayne, IN, Biltmore Beach, FL, and Winnepig, MB. The cities were chosen because of their similarity to cities in the USSR.
In St. Louis, the Army’s dispersion methods were insidious. “The Army used motorized blowers atop a low-income housing high-rise, at schools and from the backs of station wagons” to disperse the chemical agent. Local officials were told that the “government was testing a smoke screen that could shield St. Louis from aerial observation in case the Russians attacked.”
Zinc cadmium sulfide itself is a fine powder “that is formed by heating zinc sulfide and cadmium sulfide together under very high temperature so that they fuse…Zinc cadmium sulfide is not a biologic weapon; it was a tracer used by the Army to imitate or simulate the dispersion of biologic weapons.” At the time, the compound was not believed to be dangerous to humans.
Daines was referring to multiple physicians’ claims that Pitt’s statements “point to the possibility” that organs were “extracted from live fetuses.” That was based on statements the university made about minimizing ischemia time, which refers to “the time after the tissue collection procedure and before cooling for storage and transport.”
The university’s application to NIH also prompted lawmakers to question whether the university had violated fetal tissue trafficking laws as part of its federally funded “GUDMAP” research program. In applying for NIH funds, Pitt said it sought to “develop a pipeline to the acquisition, quality control and distribution of human genitourinary [urinary and genital organs and functions] samples obtained throughout development (6-42 weeks gestation).”
So far, the university has denied any wrongdoing and claimed it played no role in medical procedures. It’s unclear, however, why the university made comments about ischemia time and obtaining quality tissue.